Senate adopts bill to expand immunization access after debate over funding, liability and parental consent

DENVER — The Colorado Senate on Feb. 4 adopted Senate Bill 32, a measure sponsors said expands access to vaccines by broadening who may prescribe, dispense and administer certain immunizations and by authorizing the State Board of Health to adopt rules in addition to federal advisory guidance.

Sponsor Senator Mullica said the bill is intended to "protect the people of Colorado, ensuring that they continue to have access to vaccines." He asked colleagues for a yes vote on the committee report and the amended bill. (Sen. Mullica)

The floor session turned into extended debate over whether removing existing statutory language would expose the state to open-ended general-fund costs if federal matching dollars were not available. Opponents warned that without safeguards the state could be forced to create state-only benefits and absorb significant costs. One senator noted an estimated exposure of about $27,000,000 as a possible fiscal consequence if federal funding were lost, a figure cited during debate to underscore budget risk.

Lawmakers also sparred over liability protections in the bill and whether parents should be required to consent before pharmacists or other newly authorized providers give vaccines to minors. An amendment to reinstate a statutory bar on state general-fund spending if federal funds are absent (L4) was put to a vote and lost. An amendment requiring parental or guardian consent for minors (L5) also failed.

Amendment L6, which would have removed proposed limitations on liability for certain vaccine-related claims, was debated at length and did not pass on the floor.

Senator Kirk Meyer offered a compromise amendment (L12) that preserved the bill's substantive changes while clarifying budget oversight: any additional general-fund monies required "shall be addressed through the annual budget process," a change supporters called a safeguard for appropriations and opponents accepted as a workable compromise. L12 was adopted, and the bill as amended was ordered engrossed and placed on the calendar for third reading and final passage.

Supporters, including Sen. Mullica, framed the bill as a response to federal-level uncertainty and as a way for the state to maintain vaccine access. Critics focused on potential costs and on the policy choice to expand prescriptive authority and to add pharmacies, manufacturers and others into the supply chain language.

The committee and floor record shows multiple roll-call and voice votes on individual amendments; the final floor action adopted SB32 as amended and sent it forward in the legislative process.

What happens next: With the committee-of-the-whole report amended and adopted, SB32 was placed on the calendar for further action; the Senate will consider final passage on third reading per the chamber's schedule.